Found: 23
Select item for more details and to access through your institution.
CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 5, p. 456, doi. 10.3390/cells8050456
- By:
- Publication type:
- Article
Response relating to the article Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2022, v. 56, n. 3, p. 293, doi. 10.5603/PJNNS.a2022.0042
- By:
- Publication type:
- Article
Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2022, v. 56, n. 2, p. 187, doi. 10.5603/PJNNS.a2021.0078
- By:
- Publication type:
- Article
Quantiferon Monitor Testing Sheds Light on Immune System Disparities between Multiple Sclerosis Patients and Healthy Individuals.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2179, doi. 10.3390/ijms25042179
- By:
- Publication type:
- Article
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review.
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 1211, doi. 10.2147/NDT.S163842
- By:
- Publication type:
- Article
Autoimmune and limbic encephalitis: case series with some atypical variables in clinical practice.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 1, p. 687, doi. 10.1007/s10072-021-05563-x
- By:
- Publication type:
- Article
The direct costs of multiple sclerosis-study in the Czech Republic.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69285-4
- By:
- Publication type:
- Article
Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.851426
- By:
- Publication type:
- Article
Diagnostika roztroušené sklerózy: může docházet k chybám a omylům?
- Published in:
- Neurologie Pro Praxi, 2023, v. 24, n. 4, p. 274, doi. 10.36290/neu.2023.010
- By:
- Publication type:
- Article
Dlouhodobá účinnost a bezpečnost siponimodu u pacientů se sekundárně progresivní roztroušenou sklerózou: analýza základních dat studie EXPAND a její extenze.
- Published in:
- Neurologie Pro Praxi, 2023, v. 24, n. 3, p. 206, doi. 10.36290/neu.2023.005
- By:
- Publication type:
- Article
Roztroušená skleróza: adherence k léčbě.
- Published in:
- Neurologie Pro Praxi, 2020, p. 380
- By:
- Publication type:
- Article
Bolesti hlavy z nadužívání analgetik a detoxikace jako metoda volby v léčbě.
- Published in:
- Neurologie Pro Praxi, 2020, p. 408
- By:
- Publication type:
- Article
Jak rozpoznat a léčit bolest hlavy při nadužívání analgetické medikace.
- Published in:
- Medicina Pro Praxi, 2023, v. 20, p. 8
- By:
- Publication type:
- Article
Vysoko účinná terapie u roztroušené sklerózy.
- Published in:
- Medicina Pro Praxi, 2023, v. 20, p. 6
- By:
- Publication type:
- Article
Trojnásobné kulatiny - specialisté na léčbu roztroušené sklerózy se setkali v Brně.
- Published in:
- Česká a Slovenská Neurologie a Neurochirurgie, 2018, v. 81, n. 3, p. 365
- By:
- Publication type:
- Article
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 4, p. 331, doi. 10.1007/s40268-023-00434-6
- By:
- Publication type:
- Article
Parametr NEDA-3 z pohledu současné léčby roztroušené sklerózy.
- Published in:
- Remedia, 2023, v. 33, n. 4, p. 313
- By:
- Publication type:
- Article
Siponimod v léčbě roztroušené sklerózy - kazuistika.
- Published in:
- Remedia, 2022, v. 32, n. 3, p. 248
- By:
- Publication type:
- Article
Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1468, doi. 10.3390/jcm9051468
- By:
- Publication type:
- Article
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.593527
- By:
- Publication type:
- Article
In Silico Studies of Potential Selective Inhibitors of Thymidylate Kinase from Variola virus.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 10, p. 1027, doi. 10.3390/ph14101027
- By:
- Publication type:
- Article